Endari for the Treatment of Sickle Cell Disease
Endari ™ is an orally-administered powder form of amino acid L-glutamine indicated for the treatment of sickle cell disease.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Sickle Cell Anemia